Mannitol Oral Solution 20% from Japan
Mannitol oral solution acts as an osmotic diuretic for reducing intracranial pressure and treating oliguria. Classifies in HTS 3004.90.92.63 as a measured-dose liquid diuretic affecting water balance, put up for retail therapeutic use. Bottled in single-dose units.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Provide osmolarity testing certificates for oral mannitol solutions
• Label with renal impairment contraindications for FDA compliance
• Confirm single-dose packaging qualifies as measured-dose form